Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
暂无分享,去创建一个
Chi Zhang | J. Xia | Zhaona Fan | Shiwen Yang | Jiaxin Guo | Bin Cheng | Z. Fan | Lihong He
[1] I. Berindan‐Neagoe,et al. A novel panel of clinically relevant miRNAs signature accurately differentiates oral cancer from normal mucosa , 2022, Frontiers in Oncology.
[2] Yueyang Lai,et al. HIPK3 Inhibition by Exosomal hsa-miR-101-3p Is Related to Metabolic Reprogramming in Colorectal Cancer , 2022, Frontiers in Oncology.
[3] Hong-Jian Zhu,et al. Cancer associated-fibroblast-derived exosomes in cancer progression , 2021, Molecular Cancer.
[4] M. Zerfaoui,et al. Diagnostic and Prognostic Performance of Liquid Biopsy-Derived Exosomal MicroRNAs in Thyroid Cancer Patients: A Systematic Review and Meta-Analysis , 2021, Cancers.
[5] Chung‐Han Ho,et al. Adjuvant Radiotherapy Significantly Increases Neck Control and Survival in Early Oral Cancer Patients with Solitary Nodal Involvement: A National Cancer Registry Database Analysis , 2021, Cancers.
[6] C. Chien,et al. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis. , 2021, Oral oncology.
[7] T. Masaki,et al. MicroRNA Expression Profiles in Superficial Esophageal Squamous Cell Carcinoma before Endoscopic Submucosal Dissection: A Pilot Study , 2021, International journal of molecular sciences.
[8] Ying Luo,et al. Optimized culture methods for isolating small extracellular vesicles derived from human induced pluripotent stem cells , 2021, Journal of extracellular vesicles.
[9] Wenling Zhang,et al. Colorectal cancer prompted adipose tissue browning and cancer cachexia through transferring exosomal miR‐146b‐5p , 2020, Journal of cellular physiology.
[10] D. Schadendorf,et al. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53 , 2020, Oncogene.
[11] D. Tuveson,et al. DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS. , 2020, Physiological reviews.
[12] G. Nowicka,et al. Communication in the Cancer Microenvironment as a Target for Therapeutic Interventions , 2020, Cancers.
[13] Wei Zhang,et al. Circular RNA-0001283 Suppresses Breast Cancer Proliferation and Invasion via MiR-187/HIPK3 Axis , 2020, Medical science monitor : international medical journal of experimental and clinical research.
[14] R. Ali,et al. The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis , 2020, Cancer biology & therapy.
[15] Hubing Shi,et al. Plasma Exosomal miR-146b-5p and miR-222-3p are Potential Biomarkers for Lymph Node Metastasis in Papillary Thyroid Carcinomas , 2020, OncoTargets and therapy.
[16] Chi Zhang,et al. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[17] P. Caldeira,et al. Tumor depth of invasion and prognosis of early-stage oral squamous cell carcinoma: a meta-analysis. , 2019, Oral diseases.
[18] R. Bohle,et al. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer , 2019, Journal of Cancer Research and Clinical Oncology.
[19] Jianguo Xu,et al. miR-146b Regulates Cell Proliferation and Apoptosis in Gastric Cancer by Targeting PTP1B , 2019, Digestive Diseases and Sciences.
[20] Xin Xu,et al. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma , 2019, EBioMedicine.
[21] D. Beer,et al. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer , 2019, International journal of biological sciences.
[22] K. Tsai,et al. Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab‐based concurrent bioradiotherapy in high‐risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial , 2019, Head & neck.
[23] Yuehua Wu,et al. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer , 2019, Molecular therapy. Nucleic acids.
[24] Ming Yan,et al. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression , 2019, Journal of experimental & clinical cancer research : CR.
[25] J. Shah,et al. Survival outcomes after treatment of cancer of the oral cavity (1985-2015). , 2019, Oral oncology.
[26] P. Tan,et al. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment , 2019, Oncogene.
[27] T. Salo,et al. Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma , 2019, Journal of extracellular vesicles.
[28] K. Li,et al. Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysis. , 2019, Oral oncology.
[29] Xu Wang,et al. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5 , 2019, Genome Biology.
[30] Jianguo Zhang,et al. The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China , 2018, OncoTargets and therapy.
[31] Jianfeng Liang,et al. Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p , 2018, EBioMedicine.
[32] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[33] B. Judson,et al. Changing prognosis of oral cancer: An analysis of survival and treatment between 1973 and 2014 , 2018, The Laryngoscope.
[34] G. Pierantoni,et al. Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs. , 2018, MicroRNA.
[35] Raghu Kalluri,et al. A peek into cancer-associated fibroblasts: origins, functions and translational impact , 2018, Disease Models & Mechanisms.
[36] K. Satyamoorthy,et al. DNA methylation regulated microRNAs in human cervical cancer , 2018, Molecular carcinogenesis.
[37] M. Hazekawa,et al. miR‐200c‐3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment , 2018, Molecular carcinogenesis.
[38] Juan Wang,et al. Stromal-epithelial lactate shuttle induced by tumor-derived interleukin-1β promotes cell proliferation in oral squamous cell carcinoma , 2017, International journal of molecular medicine.
[39] J. Inazawa,et al. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma , 2016, Scientific Reports.
[40] A. Weisz,et al. The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. , 2016, Cell reports.
[41] F. Chou,et al. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma. , 2016, The Journal of clinical endocrinology and metabolism.
[42] Wei Liu,et al. miR-146b-5p within BCR-ABL1-Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells. , 2016, Cancer research.
[43] Ling Li,et al. Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype. , 2016, Cancer research.
[44] X. Bian,et al. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas , 2015, Oncotarget.
[45] J. Xie,et al. MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3 , 2015, Cellular Physiology and Biochemistry.
[46] F. Sánchez‐Madrid,et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.
[47] A. Schetter,et al. microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma , 2013, International journal of cancer.
[48] Yusuke Yoshioka,et al. Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis , 2013, The Journal of Biological Chemistry.
[49] Zengtong Zhou,et al. Upregulation of miR-31* Is Negatively Associated with Recurrent/Newly Formed Oral Leukoplakia , 2012, PloS one.
[50] E. Kimura,et al. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer , 2012, Oncogene.
[51] F. Nielsen,et al. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer , 2012, British Journal of Cancer.
[52] C. Théry. Exosomes: secreted vesicles and intercellular communications , 2011, F1000 biology reports.
[53] C. von Buchwald,et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study , 2011, British Journal of Cancer.
[54] D. Beer,et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. , 2009, Cancer research.
[55] S. Soddu,et al. HIPKs: Jack of all trades in basic nuclear activities. , 2008, Biochimica et biophysica acta.
[56] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[57] T. Hofmann,et al. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains. , 2003, Cancer research.
[58] Yongsok Kim,et al. Homeodomain-interacting Protein Kinases, a Novel Family of Co-repressors for Homeodomain Transcription Factors* , 1998, The Journal of Biological Chemistry.
[59] Yin Xiao,et al. Exosomes Extraction and Identification. , 2019, Methods in molecular biology.
[60] J. Blaquiere,et al. Homeodomain-Interacting Protein Kinases: Diverse and Complex Roles in Development and Disease. , 2017, Current topics in developmental biology.